IPO registrations (S-1, F-1) · Registrants
SPECTRUM PHARMACEUTICALS INC
- SEC CIK
- 831547 · filings on EDGAR ↗
- Name on the registration
- NEOTHERAPEUTICS INC
- Former names
- NEOTHERAPEUTICS INC (1996–2002)
- Registration
- Form S-1, first filed 1999-06-03, last 1999-11-10; 2 initial registrations, 3 amendments
- Outcome
- Final prospectus filed 1999-07-27
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 11500 S. EASTERN AVE., SUITE 240, Henderson, NV 89052
- EIN
- 93-0979187
- EDGAR entity type
- operating
- Insiders and CEO pay
- SPECTRUM PHARMACEUTICALS INC on the corporate pages
Offering terms
- Proposed price range
- $4.00–$5.00 per share (S-1/A filed 1999-07-21)
- Final price
- $9.38 per share, above the range (424B4 filed 1999-07-27)
- Shares sold
- 1,000,000
- Gross proceeds
- $9,375,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol NEOT
- Lead underwriters
- Joseph Charles & Assoc., Inc (400,000 shares); Millennium Financial Group, Inc (280,000 shares)
- Syndicate
- Financial Group, Inc; Kashner Davidson Securities Corporation (280,000); Commerzbank Capital Markets Corporation (40,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: SPECTRUM PHARMACEUTICALS, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Form 5500 plan sponsor: SPECTRUM PHARMACEUTICALS, INC. EXACT (EIN (EXACT))
- Form D issuer: SPECTRUM PHARMACEUTICALS INC EXACT (CIK (EXACT))
- Lobbying client: SPECTRUM PHARMACEUTICALS Fuzzy (name and state)
- Lobbying client: SPECTRUM PHARMACEUTICALS, INC Fuzzy (name and state)
- Lobbying client: SPECTRUM PHARMACEUTICALS, INC Fuzzy (name and state)
- Lobbying client: SPECTRUM PHARMACEUTICALS, INC. Fuzzy (name and state)
- SEC filer: SPECTRUM PHARMACEUTICALS INC EXACT (CIK (EXACT))
Filings 6
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 1999-06-03 | S-1 | S-1 (registration) | NEOTHERAPEUTICS INC | 0000892569-99-001651 ↗ |
| 1999-06-18 | S-1/A | S-1/A (amendment) | NEOTHERAPEUTICS INC | 0000892569-99-001739 ↗ |
| 1999-07-21 | S-1/A | S-1/A (amendment) | NEOTHERAPEUTICS INC | 0000892569-99-001969 ↗ |
| 1999-07-27 | 424B4 | 424B4 (final prospectus) | NEOTHERAPEUTICS INC | 0000892569-99-002011 ↗ |
| 1999-10-15 | S-1 | S-1 (registration) | NEOTHERAPEUTICS INC | 0000892569-99-002691 ↗ |
| 1999-11-10 | S-1/A | S-1/A (amendment) | NEOTHERAPEUTICS INC | 0000892569-99-002949 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 1999-07-21 | S-1/A | registration statement | $4.00–$5.00 | 1,000,000 | - | Nasdaq NEOT | 1 | from the submission text; range, shares headline, cover names 1 | document ↗ | |
| 1999-07-27 | 424B4 | final prospectus | $4.00–$5.00 | $9.38 | 1,000,000 | $9,375,000 | Nasdaq NEOT | 5 | from the submission text; range, price sentence, shares headline, proceeds table, underwriting table 4, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| SHROTRIYA RAJESH C MD | Director; Director,Officer; Director,Officer,TenPercentOwner | Chairman & CEO; Chairman, CEO & President | 88 | 2006–2018 | |
| LENAZ LUIGI MD | Director; Officer | Chief Scientific Officer | 27 | 2006–2018 | |
| KUMARIA SHYAM K | Officer | Sr. Vice President Finance; Vice President Finance | 15 | 2006–2011 | |
| Fulmer Richard | Director | 7 | 2007–2010 | ||
| Krassner Stuart Mitchell | Director | 26 | 2007–2019 | ||
| MAIDA ANTHONY E III | Director | 44 | 2007–2019 | ||
| MEHTA DILIP J MD PHD | Director | 6 | 2007–2011 | ||
| VIDA JULIUS A | Director | 8 | 2007–2010 | ||
| Cybulski Mitchell P. | Director | 7 | 2007–2010 | ||
| Arora Krishan K | Director | 5 | 2010–2012 | ||
| TIDMARSH GEORGE F | Officer | CSO and Head of R&D Operations; CSO AND HEAD OF R&D OPERATIONS | 5 | 2010–2011 | |
| Scott Brett L | Officer | Acting Chief Financial Officer | 7 | 2010–2012 | |
| Shields James | Officer | Chief Commercial Officer | 8 | 2010–2012 | |
| GUETH ANTON | Director | 3 | 2012 | ||
| Gagnon Gilles | Director | 9 | 2012–2018 | ||
| Keller Joseph Kenneth | Officer | EVP & Chief Operating Officer | 4 | 2012–2013 | |
| ALLEN LEE F MD PhD | Officer | Chief Medical Officer | 7 | 2013–2015 | |
| Turgeon Joseph W. | Director,Officer; Officer | CEO & President; Chief Commercial Officer; President & COO | 40 | 2013–2021 | |
| GUSTAFSON KURT A | Officer | EVP & Chief Financial Officer | 37 | 2013–2022 | |
| COHEN RAYMOND W | Director | 12 | 2013–2019 | ||
| Vyas Dolatrai | Director; Other | 16 | 2013–2022 | ||
| Riga Thomas J | Director,Officer; Officer | CEO & President; Chief Operating Officer; EVP, COO & CCO; See Remarks | 31 | 2017–2023 | |
| Ashton William | Director | 10 | 2018–2023 | ||
| McGahan Keith M | Officer | Chief Legal Officer; See Remarks; SVP and Chief Legal Officer | 34 | 2018–2023 | |
| Welles Bernice R | Director | 5 | 2018–2021 | ||
| Vacirca Jeff L | Director | 21 | 2018–2023 | ||
| LEBEL FRANCOIS | Officer | Chief Medical Officer | 16 | 2019–2022 | |
| CZEREPAK ELIZABETH | Director | 3 | 2019–2020 | ||
| Fischer Seth H. Z. | Director | 7 | 2020–2023 | ||
| Brennan Nora | Director; Officer | CFO; EVP & CFO; See Remarks | 7 | 2020–2023 | |
| Lim Juhyun | Director | 4 | 2022–2023 | ||
| Bradrick Brittany | Director | 3 | 2022–2023 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2016-04-28 | SPECTRUM PHARMACEUTICALS INC | Pharmaceuticals | $3,000,000 | $3,000,000 | 1 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | SPECTRUM PHARMACEUTICALS, INC. | IL | State business registries | EIN (EXACT, as the state registration reports it) |
| Plan sponsor | SPECTRUM PHARMACEUTICALS, INC. | CA | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Form D issuer | SPECTRUM PHARMACEUTICALS INC | NV | Form D private offerings | CIK (EXACT) |
| Lobbying client | SPECTRUM PHARMACEUTICALS | NV | Federal lobbying (LDA) | name and state |
| Lobbying client | SPECTRUM PHARMACEUTICALS, INC | NV | Federal lobbying (LDA) | name and state |
| Lobbying client | SPECTRUM PHARMACEUTICALS, INC | NV | Federal lobbying (LDA) | name and state |
| Lobbying client | SPECTRUM PHARMACEUTICALS, INC. | NV | Federal lobbying (LDA) | name and state |
| Paying company | Spectrum Pharmaceuticals Inc. | NV | Open Payments (drug and device company payments) | name and state |
| SEC filer | SPECTRUM PHARMACEUTICALS INC | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Spectrum Pharmaceuticals, Inc. | NV | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | SPECTRUM PHARMACEUTICALS, INC. | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, NV first:
- SKINVISIBLE, INC. NV
- CardioVascular BioTherapeutics, Inc. NV
- Praxsyn Corp NV
- EnzymeBioSystems NV
- CQENS Technologies Inc. NV
- BIOADAPTIVES, INC. NV
- BIOVIE INC. NV
- Mystic Holdings Inc./NV NV
- Option Therapeutics Inc. NV
- PHARMOS CORP NV
In other datasets, the same topic (Health) in NV:
- Nonprofit: ACTIVSTEM FOUNDATION (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health